Apotransferrin shows promise as an early treatment for stroke

Researchers from Germans Trias i Pujol Research Institute (IGTP) have discovered that administering human apotransferrin to mice models affected by intracerebral hemorrhage can mitigate the damaging effects of this severe type of stroke. This finding highlights the promising role of apotransferrin as a pre-hospital and pre-triage frontline treatment for all stroke patients. The study has been published in the journal Antioxidants.